Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18696151rdf:typepubmed:Citationlld:pubmed
pubmed-article:18696151lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:18696151lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:18696151lifeskim:mentionsumls-concept:C0021102lld:lifeskim
pubmed-article:18696151lifeskim:mentionsumls-concept:C1704922lld:lifeskim
pubmed-article:18696151lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18696151lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:18696151lifeskim:mentionsumls-concept:C0850292lld:lifeskim
pubmed-article:18696151pubmed:issue1lld:pubmed
pubmed-article:18696151pubmed:dateCreated2009-2-9lld:pubmed
pubmed-article:18696151pubmed:abstractTextThe objective of this study was to evaluate the early changes after radiofrequency ablation (RFA) in VX2 rabbit tumors implanted into the back muscles by diffusion-weighted magnetic resonance (MR) imaging and (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG PET). Percutaneous CT-guided RFA was conducted in seven rabbits with implanted VX2 tumors. VX2 tumors on the other side were untreated and served as the control. MR imaging was performed with a clinical 1.5-T instrument 2 days after RFA, and FDG-PET, using a high-resolution PET scanner for small animals, was obtained 3 days after the procedure. The mean apparent diffusion coefficient (ADC) values and radioactivity count of untreated and ablated tumors were calculated. Untreated VX2 tumors showed hyperintensity on T1-, T2-, and diffusion-weighted MR images, ring-enhanced on contrast-enhanced T1-weighted imaging, and ring-shaped FDG accumulation on FDG-PET. Ablated VX2 tumors showed slight hyperintensity on T1-, T2-, and diffusion-weighed images, slight enhancement on contrast-enhanced T1-weighted images, and low accumulation on FDG-PET. The ADC value of ablated VX2 tumors (1.52 +/- 0.24 x 10(-3) mm(2)/s) was significantly higher than that of untreated tumors (1.09 +/- 0.12 x 10(-3); p < 0.05). The tumor/muscle ratio of ablated tumors (0.5 +/- 0.3) was significantly lower than that of untreated tumors (11.6 +/- 3.2; p < 0.05). Histopathological examination confirmed the lack of viable tumor cells in the ablated lesions. The results indicate that both ADC value and FDG-PET are potentially useful markers for monitoring the early effects of RFA.lld:pubmed
pubmed-article:18696151pubmed:languageenglld:pubmed
pubmed-article:18696151pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18696151pubmed:citationSubsetIMlld:pubmed
pubmed-article:18696151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18696151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18696151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18696151pubmed:statusMEDLINElld:pubmed
pubmed-article:18696151pubmed:monthJanlld:pubmed
pubmed-article:18696151pubmed:issn1432-086Xlld:pubmed
pubmed-article:18696151pubmed:authorpubmed-author:WatanabeYasuy...lld:pubmed
pubmed-article:18696151pubmed:authorpubmed-author:NakamuraKenji...lld:pubmed
pubmed-article:18696151pubmed:authorpubmed-author:InoueYuichiYlld:pubmed
pubmed-article:18696151pubmed:authorpubmed-author:MatsuokaToshi...lld:pubmed
pubmed-article:18696151pubmed:authorpubmed-author:WadaYasuhiroYlld:pubmed
pubmed-article:18696151pubmed:authorpubmed-author:OkumaTomohisa...lld:pubmed
pubmed-article:18696151pubmed:authorpubmed-author:OhiraTomohiro...lld:pubmed
pubmed-article:18696151pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18696151pubmed:volume32lld:pubmed
pubmed-article:18696151pubmed:ownerNLMlld:pubmed
pubmed-article:18696151pubmed:authorsCompleteYlld:pubmed
pubmed-article:18696151pubmed:pagination114-20lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:meshHeadingpubmed-meshheading:18696151...lld:pubmed
pubmed-article:18696151pubmed:year2009lld:pubmed
pubmed-article:18696151pubmed:articleTitleFDG-MicroPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits.lld:pubmed
pubmed-article:18696151pubmed:affiliationDepartment of Radiology, Osaka City University Graduate School of Medicine, Osaka, Japan.lld:pubmed
pubmed-article:18696151pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18696151pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18696151lld:pubmed